“…7,12,[15][16][17][18] Therefore, to overcome such problems, a recombinant T. canis antigen has been developed 18 and its high specificity and usefulness have been demonstrated. 19,20 In Brazil, seroepidemiologic studies on human toxocariasis have been carried out in Recife, Pernambuco, 21,22 Butantã, São Paulo, 23,24 Vitória, Espírito Santo, 25 Campinas, Sã o Paulo, 26 and Brasilia, Distrito Federal, 27 and it has been reported that the prevalence rates of toxocariasis reached approximately 40% in some studies. [21][22][23] Here we report the prevalence rate of toxocariasis based on serologic analysis using the recombinant T. canis antigen in children in the suburb of Recife in northeastern Brazil.…”